EP2352484A1

EP2352484A1 - Hair conditioners comprising imidazolines and ester oils

Info

Publication number: EP2352484A1
Application number: EP09751939A
Authority: EP
Inventors: Marlene Battermann; Dieter Goddinger; Tanja BÖSEL; Christa Hartwich; Nicole Fernandes
Original assignee: Henkel AG and Co KGaA
Current assignee: Henkel AG and Co KGaA
Priority date: 2008-12-03
Filing date: 2009-11-17
Publication date: 2011-08-10
Also published as: WO2010063565A1; DE102008060147A1; US20110268684A1

Abstract

Cosmetic preparations, in particular hair conditioners, are described which contain at least one imidazoline derivative including at least two long fat groups, and at least two ester oils.

Description

"Hair conditioning agents with imidazolines and ester oils"

The invention relates to hair treatment compositions containing cationic imidazolines and the use of these agents for the treatment of skin and hair.

Not least due to the heavy use of hair, for example by dyeing or perming, as well as by the cleaning of the hair with shampoos and by environmental pollution, the importance of care products with the longest possible effect increases.

These conventional compositions contain silicones. This means that some drugs can not penetrate deep enough or not deep enough into the hair. Furthermore, in the hairstyle design, a composition with silicone has a burdening and aggravating for the hairstyle design. A voluminous hairstyle with easy combing of wet and dry hair is often not obtained with these compositions.

There is therefore still a need for active ingredients or combinations of active ingredients for cosmetic products with good care properties and good biodegradability, which are free of silicones.

Quaternary ammonium compounds of the mono-, di- and / or trialkylammonium type have been known for a long time. A disadvantage of these compounds, however, is their lack of biodegradability. Therefore, cationic compounds containing at least one ester group, the so-called ester quats, have been developed. These, however, show a sensation of being unpleasantly dull in terms of the feel and feel of wet skin and hair as well as the touch and feel of the rewashed skin or hair, which is also perceived as "squeaky" audible. Surprisingly, however, it has been found that cationic imidazolines of the formula I, in particular those which have a chain length of the radical R of at least 20 C atoms, and particularly preferably 21 C atoms, in combination with at least two cosmetic ester oils, the requirements for the hair Caring compositions meet in an excellent manner.

In a preferred embodiment, at least one further cationic compound is included. This further cationic compound is selected here from the cationic imidazolines of the formula Ib having a chain length of the radical R of from 8 to 18 C atoms, the esterquats, the cationic compounds of the formula (Tkat2) or the amidoamines and / or the quaternized amidoamines or the cationic polymeric compounds. The mandatory Ester oils present are particularly preferably selected from the esters of carbonic acid with fatty alcohols, in particular selected from the symmetrical esters of carbonic acid with fatty alcohols, and / or the esters of fatty acids with fatty alcohols and / or an ester oil of the structural formula (D4-II). The inventively preferred embodiments contain at least one physiologically acceptable cosmetic carrier and also contain the following ingredients as shown in the respective embodiment. In no case, however, is a silicone included. Embodiment 1:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one amine and / or cationized amine, in particular at least one

Amidoamine and / or a cationized amidoamine, embodiment 2:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one imidazoline derivative of the formula Ib, embodiment 3:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one esterquat embodiment 4:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one cationic surfactant of the formula (Tkat2) Embodiment 5:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one amine and / or cationized amine, in particular at least one

Amidoamine and / or a cationized amidoamine,

At least one imidazoline derivative of the formula Ib Embodiment 6:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one amine and / or cationized amine, in particular at least one

Amidoamine and / or a cationized amidoamine,

At least one esterquat embodiment 7:

At least one imidazoline derivative of the formula Ia,

At least two ester oils, At least one amine and / or cationized amine, in particular at least one

Amidoamine and / or a cationized amidoamine,

At least one cationic surfactant of formula (Tkat2) Embodiment 8:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one imidazoline derivative of the formula Ib,

At least one esterquat embodiment 9:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one imidazoline derivative of the formula Ib,

At least one cationic surfactant of formula (Tkat2) Embodiment 10:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one cationically charged polymeric compound,

At least one esterquat

At least one cationic compound of the formula (Tkat2) Embodiment 11:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one esterquat

At least one amine and / or cationized amine, in particular at least one

Amidoamine and / or a cationized amidoamine,

At least one cationic surfactant of the formula (Tkat2) Embodiment 12:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one esterquat

At least one amine and / or cationized amine, in particular at least one

Amidoamine and / or a cationized amidoamine,

At least one imidazoline derivative of formula Ib Embodiment 13:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one cationic surfactant of the formula (Tkat2),

At least one amine and / or cationized amine, in particular at least one

Amidoamine and / or a cationized amidoamine,

At least one imidazoline derivative of the formula Ib Embodiment 14:

At least one imidazoline derivative of the formula Ia,

At least two ester oils,

At least one esterquat,

At least one amine and / or cationized amine, in particular at least one

Amidoamine and / or a cationized amidoamine,

At least one cationic surfactant of the formula (Tkat2)

At least one imidazoline derivative of the formula Ib

Particularly preferably, the abovementioned embodiments contain at least three ester oils. It is also highly preferred if not only at least three ester oils are used in the abovementioned embodiments, but furthermore at least one cationically charged polymeric compound is contained.

The use of these combinations leads to surprisingly good properties of the treated skin and hair, which clearly outweigh the effects of comparable compositions with silicone. In this case, the compositions according to the invention have all the advantages of silicone-containing compositions, but without their major disadvantages.

A first subject of the present invention is therefore a composition for the treatment of keratinic fibers, comprising a) at least 0.01% by weight of a cationic imidazoline derivative having at least two long fat residues according to formula Ia and b) at least two ester oils and c) a cosmetic carrier and d) no silicone.

The compositions according to the invention contain an active ingredient combination of at least two constituents, the constituents a) and b) being used within a certain weight ratio to one another. In preferred agents according to the invention, the weight ratio of imidazoline derivatives a) of the formula Ia to one of the other cationically charged polymeric compound b) is 50: 1 to 1:50, preferably 20: 1 to 1:20, particularly preferably 10: 1 to 1:10 , particularly preferably 5: 1 to 1: 5. These ratios are also in the embodiments of the invention with at least one other cationic surfactant with respect to the sum of the total contained cationic surfactants. In the embodiments according to the invention in which more than 2 further cationic surfactants are present, it is preferred according to the invention for these ratios to apply exclusively with respect to the imidazoline derivative of the formula Ia. In this particular case, it is most preferred if the weight ratio of components a) to b) is between 3: 1 and 1: 3. Ingredients a) and b) are described in detail below. As far as below the active ingredient complex (A) is spoken, this statement refers to the ingredients contained in the inventive compositions a), and b). Hair treatment compositions according to the present invention are, for example, hair dyes,

Bleaching agents, hair shampoos, hair conditioners, conditioning shampoos, hair sprays,

Hair rinses, hair treatments, hair wraps, hair tonics, perming solutions,

Hair dye shampoos, hair dyes, hair fixatives, hair dressings, hair styling preparations,

Fönwell lotions, mousses, hair gels, hair waxes or combinations thereof.

By combing is understood according to the invention both the combability of the wet fiber, as well as the combability of the dry fiber. As a measure of the combability serves the spent

Combing work or the applied force during the combing process of a fiber collective. The

Measurement parameters can be assessed by the skilled person or quantified by measuring devices.

As a handle defines the tactility of a fiber collective, the expert sensory the

Parameter abundance and suppleness of the collective feels and evaluates.

Shaping is the ability of a collective of previously treated keratin-containing

To give fibers, in particular human hair, a change of shape. Hair cosmetics also speak of hair styling.

In the context of an oxidative hair treatment, the action of an oxidative cosmetic agent containing at least one oxidizing agent on hair in a cosmetic carrier is defined according to the invention.

Suitable cosmetic vehicles according to the invention are in particular O / W, W / O and W / O / W.

Emulsions in the form of creams or gels or surfactant-containing foaming solutions, such as shampoos, foam aerosols or other preparations, in particular for the

Application on the hair are suitable. But it is also conceivable to integrate the ingredients in a powdered or tablet-like formulation, which is dissolved in water before use. The cosmetic carriers may in particular be aqueous or aqueous-alcoholic.

An aqueous cosmetic carrier contains at least 50% by weight of water.

For the purposes of the present invention, aqueous-alcoholic cosmetic carriers include aqueous solutions containing from 3 to 70% by weight of a C ₁ -C ₆ -alkyl alcohol, in particular methanol,

Ethanol or propanol, isopropanol, butanol, isobutanol, tert-butanol, n-pentanol, iso-pentanols, n-hexanol, isohexanols, glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol or 1, 6

To understand hexanediol. The agents according to the invention may additionally contain further organic

Solvents, such as, for example, methoxybutanol, benzyl alcohol, ethyl diglycol or 1, 2

Propylene glycol, included. Preference is given to all water-soluble organic solvents.

As ingredient a) the compositions according to the invention contain at least one quaternary

Imidazoline compound, i. a compound having a positively charged imidazoline ring.

The formula I shown below shows the structure of these compounds.

Formula Ia

The radicals R are each independently a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 20 to 30 carbon atoms. The preferred compounds of the formula I each contain the same hydrocarbon radical for R. The chain length of the radicals R is at least 20 carbon atoms. Preference is given to compounds having a chain length of at least 21 carbon atoms. A is a physiologically acceptable anion. According to the invention, the anionic counterion comprises halides, for example fluoride, chloride or bromide, alkyl sulfates, such as methosulfate or ethosulfate, phosphates, citrate, tartrate, maleate or fumarate. A commercial product of this chain length is known, for example, under the name Quaternium-91.

The imidazolines of the formula Ia are present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.01 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight. % contain. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.

As ingredient b) ester oils are used. The ester oils are defined as follows: Ester oils are to be understood as meaning the esters of C ₆ - C ₃₀ fatty acids with C ₂ - C ₃₀ fatty alcohols. The monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred. Examples of fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and Erucic acid and its technical mixtures. Examples of the fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, Gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures.

According to the invention, particularly preferred are isopropyl myristate (IPM Rilanit ^®), isononanoic acid-C16 18-alkyl ester (Cetiol ^® SN), 2-ethylhexyl palmitate (Cegesoft ^® 24), stearic acid-2-ethylhexyl ester (Cetiol ^® 868), cetyl oleate, glycerol tricaprylate, Kokosfettalkohol- caprate / caprylate (Cetiol ^® LC), n-butyl stearate, oleyl erucate (Cetiol ^® J 600), isopropyl palmitate (IPP Rilanit ^®), oleyl Oleate (Cetiol ^®), Laurate (Cetiol A), di-n-butyl adipate (Cetiol B), myristyl myristate (Cetiol MM), Cetearyl Isononanoate (Cetiol ^® SN), decyl oleate (Cetiol ^® V).

Of course, the ester oils may also be alkoxylated with ethylene oxide, propylene oxide, or mixtures of ethylene oxide and propylene oxide. The alkoxylation can be found both on the fatty alcohol part and on the fatty acid part and on both parts of the ester oils. However, preference is given according to the invention if the fatty alcohol was first alkoxylated and then esterified with fatty acid. In the formula (D4-II), these compounds are generally shown.

R 1 is a saturated or unsaturated, branched or unbranched, cyclic saturated cyclic unsaturated acyl radical having 6 to 30 carbon atoms, AO is ethylene oxide, propylene oxide or butylene oxide,

X is a number between 1 and 200, preferably 1 and 100, more preferably between 1 and 50, most preferably between 1 and 20, most preferably between 1 and 10 and most preferably between 1 and 5,

R 2 represents a saturated or unsaturated, branched or unbranched cyclic saturated cyclic unsaturated alkyl, alkenyl, alkynyl, phenyl or benzyl radical having from 6 to 30 carbon atoms. Examples of fatty acid moieties used as radical R1 in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid , Gadoleic acid, behenic acid and erucic acid and their technical mixtures. Examples of the fatty alcohol moieties R2 in the ester oils are benzyl alcohol, isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol , Arachylalkohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures. A particularly preferred according to the invention is Esteröl example, under the INCI - available name PPG-3 benzyl ether myristate, for example the commercial product Crodamol STS ^®. Furthermore, ester oils are to be understood as meaning:

Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate, and diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate,

Propylene glycol di-pelargonate, butanediol diisostearate, neopentyl glycol, as well as symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, for example glycerol carbonate or dicaprylyl carbonate (Cetiol ^® CC), Trifatty acid esters of saturated and / or unsaturated linear and / or branched fatty acids with glycerol,

Fatty acid partial glycerides, ie monoglycerides, diglycerides and their technical mixtures. With the use of technical products production reasons may still contain small amounts of triglycerides. The partial glycerides preferably follow the formula (D4-I),

CH ₂ O (CH ₂ CH ₂ O) _m R ¹

CHO (CH ₂ CH ₂ O) _n R ² (D4-I)

CH ₂ O (CH ₂ CH ₂ O) _q R ³ in the R ¹ , R ² and R ^{3 is} independently of one another hydrogen or a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22, preferably 12 to 18, Carbon atoms are provided with the proviso that at least one of these groups is an acyl radical and at least one of these groups is hydrogen. The sum (m + n + q) is 0 or numbers from 1 to 100, preferably 0 or 5 to 25. Preferably, R ^{1 is} an acyl radical and R ² and R ^{3 are} hydrogen and the sum (m + n + q) is 0. Typical examples are mono- and / or diglycerides based on caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid , Linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures. Preferably, oleic acid monoglycerides are used.

The ester oils are present in the compositions according to the invention in an amount of from 0.01 to 20% by weight, preferably from 0.01 to 10.0% by weight, particularly preferably from 0.01 to 7.5% by weight, most preferably from 0, 1 to 5.0 wt.% Used. Of course, it is also possible according to the invention to use more than two ester oils at the same time. In each case, the ester oils are selected so that the ester oils are combined according to their Spreitwerten. It has been found according to the invention that it is particularly advantageous when a fast-spreading ester oil is combined with a slowly spreading ester oil. It is particularly advantageous if at least 3 or more ester oils are combined with one another. Here, the spreading, so a simple and particularly effective dispersibility of the entire composition on the hair, can be realized in an excellent manner. For this purpose, in addition to a particularly slowly spreading ester oil and a particularly fast-spreading ester oil, at least one further, preferably several ester oils are used, which lie in their Spreitverhalten between the slowly spreading and the fast-spreading ester oil.

The spreading behavior of ester oils can be determined very easily and simply by a person skilled in the art. A first rough approximation is the molecular weight. As the molecular weight increases, the spreading speed decreases to a first approximation. In particular, the smoothness of the hair is affected by these oil components. Fast-spreading ester oils leave a distinct smoothness. Slow-spreading ester oils leave a clearly long-lasting but not so pronounced smoothness. However, not only the smoothness is affected. Spreading also affects the distribution of the entire composition on the hair. In particular, the use of at least two, more preferably 3 ester oils, of which in turn at least one, an ester oil from a fatty acid with a fatty alcohol, particularly preferably isopropyl myristate, and another must be an ester of carbonic acid with fatty alcohol, preferably with dicaprylyl , achieved a uniform effect and distribution of the composition of the invention on the hair. When using at least two ester oils, the ester oils are used in approximately equal weight amounts. Preferred is the use of slightly higher levels of the fast spreading component. The preferred ratio is 1: 1 to 2: 1. If at least three ester oils are present in the compositions according to the invention, the third ester oil is an ester oil of the formula (D4-II). Most preferred in this case is the use of the ester oil PPG-3 benzyl ether myristate.

Another particularly preferred ingredient is at least one cationically charged polymeric compound. Cationic polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be "temporary" or "permanent" cationic.

Further cationic polymers according to the invention are the so-called "temporary cationic" polymers, which usually contain an amino group which, at certain pH values, is present as a quaternary ammonium group and thus cationically.

Both cationic and amphoteric or zwitterionic polymers can therefore be characterized by their cationic charge density. The polymers of the invention are characterized by a charge density of at least 1 to 7 meq / g. A charge density of at least 2 to 7 meq / g is preferred. Particularly preferred is a charge density of at least equal to 3meq / g to 7 meq / g.

Another characteristic feature of the polymers according to the invention is their molecular weight. The molecular weight of the particular polymer is understood to mean the molecular weight which the manufacturer indicates in the corresponding data sheets by its method. For the selection of a suitable polymer, a molecular weight of at least 50,000 g / u has proven to be suitable according to the invention. Polymers with a molecular weight of more than 100,000 g / u have proven to be particularly suitable. Polymers with a molecular weight of more than 1,000,000 g / u are particularly suitable.

Suitable polymers have a value of greater than 50,000 for the product of cationic charge density and molecular weight. Particularly suitable are polymers which have a value of at least 100,000 for this product. Especially suitable are those polymers in which this product has a value greater than 150,000. Most suitable are those polymers in which this product has a value of at least 1,000,000.

Preference is given to those polymers which have a sufficient solubility in water or alcohol in order to completely dissolve in the agent according to the invention. The cationic polymers may be homo- or copolymers, the quaternary

Nitrogen groups are contained either in the polymer chain or preferably as a substituent on one or more of the monomers. The ammonium group-containing monomers may be copolymerized with non-cationic monomers. Suitable cationic monomers are unsaturated, radically polymerizable compounds which are at least one cationic

Wear group, in particular ammonium-substituted vinyl monomers such as

Trialkylmethacryloxyalkylammonium, trialkylacryloxyalkylammonium, dialkyldiallylammonium and quaternary vinylammonium monomers containing cyclic, cationic nitrogens

Groups such as pyridinium, imidazolium or quaternary pyrrolidones, e.g. alkylvinylimidizolium,

Alkylvinylpyridinium, or Alyklvinylpyrrolidon salts. The alkyl groups of these monomers are preferably lower alkyl groups such as C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.

The ammonium group-containing monomers may be copolymerized with non-cationic monomers. Suitable comonomers are, for example, acrylamide, methacrylamide; Alkyl and dialkyl acrylamide, alkyl and dialkyl methacrylamide, alkyl acrylate, alkyl methacrylate,

Vinylcaprolactone, vinylcaprolactam, vinylpyrrolidone, vinylester, e.g. Vinyl acetate, vinyl alcohol,

Propylene glycol or ethylene glycol, wherein the alkyl groups of these monomers preferably C1 to

C7 alkyl groups, more preferably C1 to C3 alkyl groups.

Suitable polymers with quaternary amine groups are, for example, those in CTFA Cosmetic

Ingredient Dictionary described under the names Polyquaternium polymers such

Methylvinylimidazolium chloride / vinylpyrrolidone copolymer (Polyquaternium-16) or quaternized

Vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer (Polyquaternium-11).

Among the cationic polymers which may be included in the composition of the invention is, for example, vinylpyrrolidone / dimethylaminoethyl methacrylate methosulfate copolymer, which is among the

Trade names Gafquat ^® 755 N and Gafquat ^® 734 marketed by Gaf Co., USA and of which the Gafquat ^® 734 is particularly preferred suitable. Further cationic

Polymers are, for example, those of the company BASF, Germany under the trade name

Luviquat.RTM ^® HM 550 displaced copolymer of polyvinylpyrrolidone and imidazoliminemethochloride that ^® by Calgon / USA under the trade name Merquat Plus 3300 sold

Terpolymer of dimethyldiallylammonium chloride, sodium acrylate and acrylamide and that of the

Company ISP sold under the trade name Gafquat ^® HS 100 vinylpyrrolidone / methacryl amidopropyltrimethylammonium chloride copolymer.

Homopolymers of the general formula (P1),

- (CH ₂ - [CR ¹ COO- (CH ₂ ) _m N ⁺ R ² R ³ R ⁴ ]} _n X ^" (P1) in which R ^{1 is} -H or -CH ₃ ,

R ² , R ³ and R ^{4 are} independently selected from C 1-4 -alkyl, -alkenyl or

Hydroxyalkyl groups, m = 1, 2, 3 or 4, n is a natural number and X ^'is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (monomer-3) and nonionic monomer units, are particularly preferred cationic polymers. In the context of these polymers, preference is given to those according to the invention for which at least one of the following conditions applies:

R ¹ is a methyl group

R ² , R ³ and R ⁴ are methyl groups m has the value 2.

Suitable physiologically acceptable counterions X ^' are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions. Preference is given to halide ions, in particular chloride. A particularly suitable homopolymer is the optionally crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium 37. Such products are, for example, under the names Rheocare ^® CTH (Cosmetic Rheologies) and Synthalen ^® CR (3V Sigma) are commercially available. If desired, the crosslinking can be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose. Methylenebisacrylamide is a preferred crosslinking agent.

The homopolymer is preferably used in the form of a nonaqueous polymer dispersion which should not have a polymer content of less than 30% by weight. Such polymer dispersions are available under the names Salcare ^® SC 95 and Salcare ^® SC 96 in the trade. Copolymers with monomer units of the formula (Pmonomer-3) contain, as nonionic monomer units, preferably acrylamide, methacrylamide, acrylic acid-C-. _4- alkyl esters and methacrylic acid-C-ι- ₄ -alkyl ester. Among these nonionic monomers, the acrylamide is particularly preferred. These copolymers can also be crosslinked, as described above in the case of the homopolymers. A copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer. Such copolymers in which the monomers are present in a weight ratio of about 20:80, are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ^® SC. Suitable cationic polymers derived from natural polymers are cationic derivatives of polysaccharides, for example, cationic derivatives of cellulose, starch or guar. Also suitable are chitosan and chitosan derivatives. Cationic polysaccharides have the general formula (P-3) GOB-N + R _a R _b R _c X ^"

G is an anhydroglucose residue, for example starch or cellulose anhydroglucose; B is a divalent linking group, for example, alkylene, oxyalkylene, polyoxyalkylene or hydroxyalkylene; R _a , R _b and R _c are independently alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl or alkoxyaryl each having up to 18 carbon atoms, wherein the total number of carbon atoms in R _a , R _b and R _{c is} preferably not more than 20 is;

X ^" is a common counteranion and is preferably chloride.

A cationic cellulose is sold under the name Polymer JR 400 from Amerchol ^® and has the INCI designation Polyquaternium-10 degrees. Another cationic cellulose bears the INCI name Polyquaternium-24 and is sold under the trade name Polymer LM-200 by Amerchol. Other commercial products are the compounds Celquat ^® H 100, Celquat ^® L and 200. The commercial products mentioned are preferred cationic celluloses. Suitable cationic guar derivatives are marketed under the trade name Jaguar ^® and have the INCI name guar hydroxypropyltrimonium chloride. Further particularly suitable cationic guar derivatives are also used by the company. Hercules under the name N-Hance ^® commercially. Other cationic guar derivatives are marketed by the company. Cognis under the name Cosmedia® ^®. A preferred cationic guar derivative is the commercial product AquaCat® ^® from. Hercules. This raw material is an already pre-dissolved cationic guar derivative.

Another particularly useful cationic natural polymer is chitosan type hydrocolloids. Unlike most hydrocolloids, which are negatively charged at biological pH levels, chitosans are cationic biopolymers under these conditions.

A suitable chitosan is sold, for example, by Kyowa Oil & Fat, Japan under the trade name Flonac ^®. A preferred chitosan is chitosoniumpyrrolidone is, for example, sold under the name Kytamer ^® PC by Amerchol, USA. Suitable chitosan derivatives are quaternized, alkylated or hydroxyalkylated derivatives, for example hydroxyethyl or hydroxybutylchitosan. Further chitosan derivatives are Hydagen® ^® CMF, Hydagen® ^® HCMF and Chitolam ^® NB / 101 freely available under the trade names in the trade. More preferred cationic polymers include cationic alkyl polyglycosides, cationized honey, for example the commercial product Honeyquat 50 ^®, polymeric dimethyldiallylammonium salts and their copolymers thereof with esters and amides of acrylic acid and methacrylic acid. Under the names Merquat ^® 100 (Poly (dimethyldiallylammonium chloride)) and Merquat ^® 550 (dimethyldiallylammonium chloride-acrylamide copolymer) are examples of such cationic polymers,

Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as diethyl sulfate quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers. Such compounds are sold under the names Gafquat ^® 734 and Gafquat ^® 755 commercially, Vinylpyrrolidone Vinylinnidazoliunnnnethochlorid-Copolynnere, such as those offered under the names Luviquat ^® FC 370, FC 550, FC 905 and HM 552, quaternized polyvinyl alcohol, as well as by the names of Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27, having quaternary Nitrogen atoms in the polymer backbone,

Vinylpyrrolidone-vinylcaprolactam-acrylate terpolymers, such as those offered with acrylic acid esters and acrylamides as the third monomer building commercially, for example, under the name Aquaflex ^® SF 40.

, Gaffix ^® VC 713 (manufactured by ISP): Also according to the invention can be used the copolymers of vinylpyrrolidone, such as the commercial products Copolymer 845 (ISP manufacturer) are Gafquat ^® ASCP 1011, Gafquat ^® HS 110, Luviquat ^® 8155 and Luviquat ^® MS 370 available are. According to the invention preferred cationic polymers are cationic CeIIu lose-derivatives and chitosan and its derivatives, in particular the commercial products Polymer ^® JR 400, Hydagen ^® HCMF and Kytamer ^® PC, cationic guar derivatives, cationic honey derivatives, in particular the commercial product Honeyquat ^® 50, cationic Alkyl polyglycodides and Polyquaternium-37 type polymers.

Furthermore, cationized protein hydrolysates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates. Preference is given to those cationic protein hydrolyzates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons. Furthermore, cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof. Furthermore, the cationic protein hydrolysates may also be further derivatized. As typical examples of the cationic protein hydrolysates and derivatives according to the invention, those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 ^th Street, NW, Suite 300 Washington, DC 20036-4702) and commercially available products. Very particular preference is given to the cationic protein hydrolysates and derivatives based on plants.

The cationic polymers are contained in the compositions according to the invention preferably in amounts of 0.01 to 10 wt .-%, based on the total agent. Levels of 0.05 to 5 wt .-% are particularly preferred.

Amphoteric polymers, like the cationic polymers, are most preferred polymers. The term amphoteric polymers includes both those polymers which contain in the molecule both free amino groups and free -COOH or SO ₃ H groups and are capable of forming internal salts, as well as zwitterionic polymers which have quaternary groups in the molecule Ammonium groups and -COO - or -SO ₃ ^~ groups, and those polymers comprising -COOH or SO ₃ H groups and quaternary ammonium groups. Amphoteric and / or cationic polymers preferred according to the invention are those polymers in which a cationic group is derived from at least one of the following monomers: monomers with quaternary ammonium groups of the general formula (monol), R ¹ -CH = CR ² -CO-Z- ( C _n H _2n ) -N ⁽⁺⁾ R ³ R ⁴ R ⁵ A ⁽⁾ (monol) in which R ¹ and R ² independently of one another represent hydrogen or a methyl group and R ³ , R ⁴ and R ⁵ independently of one another represent alkyl groups with 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer from 2 to 5 and A ^{() is} the anion of an organic or inorganic acid,

Monomers having quaternary ammonium groups of the general formula (Mono 2),

wherein R ⁶ and R ⁷ independently of one another represent a (C 1 to C ₄ ) -alkyl group, in particular a methyl group and

A ^'is the anion of an organic or inorganic acid.

When a cationic group of the amphoteric or cationic polymers is derived from the monomer of the formula (monol), the radicals R ³ , R ⁴ and R ⁵ in the formula (monol) are preferably methyl groups, Z is preferably an NH group and A ^{( )} preferably means a halide, methoxysulfate or ethoxysulfate ion. It is particularly preferred in this case to use acrylamidopropyltrimethylammonium chloride as the monomer (monol). In formula (Mono2), A ^' preferably represents a halide ion, in particular chloride or bromide Preferred amphoteric polymers according to the invention are polymers whose anionic group derives from at least one monomer of the formula (Mono3) monomeric carboxylic acids of the general formula (Mono3) or their salts with an organic or inorganic acid,

R ⁸ -CH = CR ⁹ -COOH (mono 3) in which R ⁸ and R ^{9 are} independently hydrogen or methyl groups. As the monomer (Mono3) acrylic acid is used for the inventively preferred amphoteric polymers.

Particularly preferred amphoteric polymers are copolymers of at least one monomer (monol) or (mono 2) with the monomer (mono 3), in particular copolymers of the monomers (mono 2) and (mono 3). Very particularly preferably used according to the invention amphoteric polymers are copolymers of diallyl dimethyl ammonium chloride and acrylic acid. These copolymers are sold under the INCI name Polyquaternium-22, among others, with the trade name Merquat ^® 280 (Nalco).

In addition, in addition to a monomer (monol) or (mono 2) and a monomer (mono 3), the amphoteric polymers according to the invention may additionally contain one monomer (mono 4). monomeric carboxamides of the general formula (mono 4), R ¹⁰ -CH = CR ¹¹ -C-NH-R ¹² (mono 4)

O in which R ¹⁰ and R ^{11 are} independently hydrogen or methyl groups and R ^{12 is} a hydrogen atom or a (C ₁ - to C ₈ ) alkyl group containing.

Amphoteric polymers based on a comonomer (Mono4) which are very particularly preferably used according to the invention are terpolymers of diallyldimethylammonium chloride, acrylamide and acrylic acid. These copolymers are marketed ^® under the INCI name Polyquaternium-39, among others, with the trade name Merquat Plus 3330 (Nalco).

Particularly preferred amphoteric polymers are those polymers which are composed essentially

(i) monomers having quaternary ammonium groups of the general formula (monol), R ¹ -CH = CR ² -CO-Z- (C _n H _2n ) -N ⁽⁺⁾ R ² R ³ R ⁴ A ⁽⁾ (monol) in R ¹ and R ² independently of one another represent hydrogen or a methyl group and R ³ , R ⁴ and R ⁵ independently of one another represent alkyl groups having 1 to 4 carbon atoms, Z denotes an NH group or an oxygen atom, n denotes an integer of 2 to 5 and A ^{() is} the anion of an organic or inorganic acid and

(ii) monomeric carboxylic acids of the general formula (mono 3), R ⁸ -CH = CR ⁹ -COOH (mono 3) in which R ⁸ and R ⁹ independently of one another are hydrogen or methyl groups. Very particular preference is given to those polymers in which monomers of the type (i) are used in which R ³ , R ⁴ and R ^{5 are} methyl groups, Z is an NH group and A ^{() is} a halide, methoxysulfate or ethoxysulfate ion is; Acrylamidopropyltrimethylammonium chloride is a particularly preferred monomer (i). As the monomer (ii) for the polymers mentioned, acrylic acid is preferably used.

The amphoteric polymers can generally be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention.

The amphoteric polymers are contained in the agents according to the invention preferably in amounts of 0.01 to 10 wt .-%, based on the total agent. Amounts of 0.01 to 5 wt .-% are particularly preferred.

The preferred cationic polymeric compounds according to the invention, as described above, are in particular selected from the cationic celluloses, the cationic guar derivatives, the cationic starches and the Salcare types and the Merquat types. The most preferred cationic polymeric compounds are Polyquaternium-37, Polyquaternium-80, Polyquaternium-22, Polyquaternium-10, Polyquaternium-11 and Polyquaternium-16.

In the most preferred embodiments of the present invention, at least one of the aforementioned cationic polymeric compounds is used as the ingredient in each case. there For example, the embodiments are most preferred when polyquaternium-37 or polyquaternium-10 or both are used together as the cationic polymer. Another ingredient in the compositions according to the invention is at least one further quaternary imidazoline compound, ie a compound which has a positively charged imidazoline ring. The formula Ia previously shown in the description of the mandatory ingredient a) also corresponds in principle to the structure of these compounds, it being noted, however, that the radicals R have a chain length of 8 to 18 carbon atoms.

Formula Ib

The radicals R are each independently a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 18 carbon atoms. The preferred compounds of the formula I each contain the same hydrocarbon radical for R. The chain length of the radicals R is preferably 12 to 18 carbon atoms. Particularly preferred are compounds having a chain length of at least 16 carbon atoms and most preferably having 18 carbon atoms. Preferred radicals R are oleyl, palmityl and stearyl. Counterions according to the invention are halides, such as fluoride, chloride or bromide, alkyl sulfates, such as methosulfate or ethosulfate, phosphates, citrate, tartrate, maleate or fumarate. Examples according to the invention are obtainable, for example, under the INCII names Quaternium-27, Quaternium-72 and Quaternium-83. The imidazolines as ingredients are present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.05 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight. contain. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.

As very particularly preferred further cationic surfactants in addition to the combinations according to the invention of the cationic imidazolines a), cationic surfactants of the formula (Tkat-2) are used. Not only are these cationic surfactants biodegradable, they are also particularly mild on both the mucous membrane and the skin in particular. RCO-XN ⁺ R ¹ R ² R ³ R ⁴ A ^" (Tkat-2)

R here stands for a substituted or unsubstituted, branched or straight-chain alkyl or alkenyl radical having 11 to 35 carbon atoms in the chain, X is -O- or -NR ⁵ -,

R ¹ represents an alkylene group having 2 to 6 C atoms, which may be unsubstituted or substituted, in which case substitution with an -OH or -NH group is preferred in the case of a substitution, R ² , R ³ and R ⁴ each independently represent an alkyl or hydroxyalkyl group having 1 to 6 C atoms in the chain, which chain may be straight or branched. Examples of radicals according to the invention are methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, isopentyl, neopentyl, hexyl, iso-hexyl, hydroxyalkyl, dihydroxyalkyl, hydroxyethyl, hydroxypropyl, dihydroxypropyl , Hydroxybutyl, dihydroxybutyl, trihydroxybutyl, trihydroxypropyl, dihydroxyethyl,

R5 is hydrogen or a C1 to C6 straight-chain or branched, alkyl or alkenyl radical which may also be substituted by a hydroxyl group, especially methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, iso-pentyl, neo-pentyl, hexyl, iso -hexyl, hydroxyethyl, hydroxypropyl, dihydroxypropyl, hydroxybutyl, dihydroxybutyl, trihydroxybutyl, trihydroxypropyl, dihydroxyethyl and

A ^' represents a halide such as fluoride, chloride or bromide, an alkyl sulfate such as a methosulfate or ethosulfate, a phosphate, a citrate, tartrate, maleate or fumarate

Within this structural class, the compounds of one of the following structures are preferably used:

CH ₃ (CH ₂₎ ₂ OCONH (CH ₂₎ ₃ - N ⁺ (CHs) ₂ -CH ₂ CH ₃ A ^"(Tkat-3)

CH ₃ (CH ₂ ) ₂₀ CONH (CH ₂ ) ₃ - N ⁺ (CH ₃ ) ₂ -CH ₂ (CHOH) CH ₂ OH A ^" (Tkat-4)

CH ₃ (CH 2) ₂₀ COOCH ₂ CHOHCH ₂ - N ⁺ (CH ₃ ) ₃ A ^" (Tkat-5)

CH ₃ (CH ₂ ) ₂₀ CONH (CH ₂ ) ₃ - N ⁺ (CH ₃ ) ₂ -CH ₂ CH ₂ OH A ^" (Tkat-6)

Examples of such commercial products are Schercoquat BAS, Lexquat AMG-BEO, Akypoquat 131 or Incroquat Behenyl HE.

Even small amounts of the aforementioned cationic surfactants, especially those which satisfy the formulas (Tkat-3) to (Tkat-6) are sufficient to significantly improve the compositions according to the invention not only in the effects on skin and hair. Rather, the entire composition is thereby significantly improved, especially in their dermatological compatibility. Conventional cosmetic compositions, such as mascara, eye shadow, lipstick, hair conditioners, hair sprays or leave-on products for use on the hair can be quite noticeable when they are used and thus irritate the eyes significantly. The compositions of the invention are characterized by a significantly lower irritation, and this despite their share of well-spreading ester oils. In particular, it is even possible to claim compositions according to the invention as "no more tears".

The cationic surfactants of the formula (Tkat-2) are present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.01 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.

Furthermore, in one embodiment, esterquats according to the formula (Tkat1-2) can be used.

Here, the radicals R1, R2 and R3 are each independently and may be the same or different. The radicals R 1, R 2 and R 3 are: a branched or unbranched alkyl radical having 1 to 4 carbon atoms which may contain at least one hydroxyl group, for example methyl, ethyl, propyl,

Isopropyl, butyl, isobutyl, t-butyl, hydroxyethyl, hydroxymethyl, or a saturated or unsaturated, branched or unbranched or a cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxyl group, or an aryl or alkaryl radical, for example Phenyl or benzyl, the radical (--A - R4), with the proviso that at most 2 of the radicals R1, R2 or R3 can stand for this radical:

The remainder - (A - R4) is contained at least 1 to 3 times.

Herein A stands for:

1) - (CH 2) n - with n = 1 to 20, preferably n = 1 to 10 and particularly preferably n = 1 - 5, or

2) - (CH 2 -CHR 5 -O) n - where n = 1 to 200, preferably 1 to 100, more preferably 1 to 50, and particularly preferably 1 to 20 with R 5 in the meaning of hydrogen, methyl or ethyl, and R 4 stands for:

1) R 6 -O-CO-, wherein R 6 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and or 1 to 100 propylene oxide units may be ethoxylated, or

2) R7-CO-, wherein R7 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and / or Q is a physiologically acceptable organic or inorganic anion, which is preferably selected from the halides, for example fluoride, chloride, bromide, the sulfates, for example the Methosulfaten the general formula RSO ₃ ^" wherein R is the Meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms, the phosphates or anionic organic acid residues such as maleate, fumarate, oxalate, tartrate, citrate, lactate or acetate.

Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element. Preferred esterquats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines. Such products are marketed under the trademarks Rewoquat ^®, Stepantex® ^®, ^® and Dehyquart® Armocare® ^®. The products Armocare ^® VGH-70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ^® F-75, Dehyquart ^® C-4046, Dehyquart ^® L80, Dehyquart ^® F-30, Dehyquart ^® AU 35, Rewoquat ^® WE18, Rewoquat WE38 ^® DPG and Stepantex ^® GS 90 are examples of such esterquats.

Further compounds of the formula (Tkat1-2) which are particularly preferred according to the invention belong to the formula (Tkat1-2.1), the cationic betaine esters.

)

R8 corresponds in its meaning R7.

The esterquats are present in the compositions of the invention in amounts of from 0.01 to 20

% By weight, preferably in amounts of from 0.01 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight. The best results are obtained with amounts of 0.1 to

5% by weight in each case based on the total composition of the respective agent.

As a further ingredient monoalkyltrimethylammonium salts can in one embodiment with a

Chain length of the alkyl radical of 16 to 24 carbon atoms.

These compounds have the structure shown in the formula (Tkat1-1)

R1 R4-N-R2

R3

(Tkat1-1)

Wherein R1, R2 and R3 are each a methyl group and R4 is a saturated, branched or unbranched alkyl radical having a chain length of 16 to 24 carbon atoms and A is an anion selected from the physiologically acceptable anions. Exemplary of the anion are the halides, fluoride, chloride, bromide, sulfate (methosulfate) of the general formula RSO ₃ ^" in which R has the meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms, or anionic radicals of organic acids such as maleate, fumarate, Oxalate, tartrate, citrate, lactate or acetate.

Particularly preferred compounds of the formula (Tkat1-1) have as anion the chloride or methosulfate with a methyl group as the radical R, and furthermore as the radical R4 a saturated, branched or unbranched alkyl radical, very particularly preferably unbranched alkyl radical a chain length of 18 to 24, most preferably with a chain length of 22 to 24

Carbon atoms.

Examples of compounds of the formula (Tkat1-1) are cetyltrimethylammonium chloride,

Cetyltrimethylammonium bromide, cetyltrimethylammonium methosulfate,

Stearyltrimethylammonium chloride, behenyltrimethylammonium chloride,

Behenyltrimethylammonium bromide and behenyltrimethylammonium methosulfate. Preferred are

Cetyltrimethylammonium and behenyltrimethylammonium salts. Particularly preferred are the latter in the form of methosulfates and bromides. Most preferred are

Cetyltrimethylammonium methosulfate and behenyltrimethylammonium methosulfate and most preferred is behenyltrimethylammonium methosulfate.

The compounds of the formula (Tkat1-1) are used in the compositions according to the invention in an amount of 0.01 to 5.0% by weight. Preferably, 0.1 to 5.0 wt.% Are used. Particular preference is given to amounts of from 0.1 to 3.0% by weight. The quantities are based on the total composition.

In a particularly preferred embodiment of the invention, the inventive

Means further at least one amine and / or cationized amine, in particular an amidoamine and / or a cationized amidoamine having the following structural formulas:

R ¹ --NH - (CH ₂ ) _n --NR ² R ³ (Tkat7) and / or

R ¹ -NH- (CH ₂ ) _n -NR ² R ³ R ⁴ (Tkatδ) wherein R ^{1 is} an acyl or alkyl radical having 6 to 30 C atoms, which may be branched or unbranched, saturated or unsaturated, and wherein the acyl radical and / or the alkyl radical may contain at least one OH group, and

R 2, R 3 and R 4 are each, independently of one another, hydrogen or an alkyl radical having 1 to 4 C

Atoms which may be the same or different, saturated or unsaturated, and

X ^'is an anion and n is an integer between 1 and 10.

The anion is selected from the physiologically acceptable anions. Examples of these are the halide ions, fluoride, chloride, bromide, sulfate of the general formula RSO ₃ ^" , wherein R is the

Has meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms, or anionic organic acid residues such as maleate, fumarate, oxalate, tartrate, citrate, lactate or

Acetate, called.

Preference is given to a composition in which the amine and / or the quaternized amine according to general formulas (Tkat7) and / or (Tkatδ) is an amidoamine and / or a quaternized

Amidoamine is where R1 is a branched or unbranched, saturated or unsaturated

Acyl radical having 6 to 30 carbon atoms, which may contain at least one OH group means.

Preference is given in this case to a fatty acid radical of oils and waxes, in particular of natural oils and waxes. Examples include lanolin, bees or candellila waxes in

Consideration.

The alkylamidoamines are usually made by amidation of natural or synthetic

Fatty acids and fatty acid sections prepared with dialkylaminoamines. Also preferred are those amidoamines and / or quaternized amidoamines in which R 2, R 3 and / or R 4 in formulas (Tkat7) and / or (Tkatδ) represent a radical according to the general formula CH ₂ CH ₂ OR 5, where R 5 is the meaning of alkyl radicals having 1 to 4 carbon atoms, hydroxyethyl or hydrogen. The preferred size of n in the general formulas (Tkat7) and / or (Tkatδ) is an integer between 2 and 5.

Also preferred are amidoamines and / or quaternized amidoamines of the general formulas (Tkat7) and / or (Tkatδ) in which the anion X ^"is a halide ion or a compound of the general formula RSO ₃ ^" , where R is the meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms.

The alkyl radical having 1 to 4 carbon atoms of R 2, R 3 and R 4 and / or the alkyl radical having 1 to 4 carbon atoms of RSO ₃ ^" in the general formula (Tkat7) and / or (Tkatδ) may contain at least one hydroxyl group.

The alkylamidoamines can both be present as such and converted by protonation in a correspondingly acidic solution into a quaternary compound in the composition. According to the invention, the cationic alkylamidoamines are preferred.

Suitable amidoamines to be used according to the invention, which may optionally be quaternized, are, for example, amidoamines: Witcamine 100 (Witco, INCI name: Cocamidopropyl Dimethylamine), Incromine BB (Croda, INCI name: behenamidopropyl dimethylamine), Mackin 401 (McIntyre, INCI name: isostearylamidopropyl dimethylamine) and other Mackine types, Adogen S1δV (Witco, INCI name: Stearylamidopropyl Dimethylamine), and as permanent cationic aminoamines: Rewoquat RTM 50 (Witco Surfactants GmbH, INCI name: Ricinoleamidopropyltrimonium Methosulfate), Empigen CSC (Albright & Wilson, INCI name: Cocamidopropyltrimonium chloride), Swanol Lanoquat DES-50 (Nikko, INCI name: Quatemium-33), Rewoquat UTM 50 (Witco Surfactants GmbH, Undecyleneamidopropyltrimonium Methosulfate). The amidoamines or quaternized amidoamines according to the general formulas (Tkat7) and (Tkatδ) can be used individually or in any desired combinations with each other, amounts of from 0.01 to 20% by weight, preferably from 0.01 to 10% by weight. and most preferably in amounts of from 0.1 to 7.5% by weight. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.

Furthermore, cosmetic oils can additionally be used with the active ingredient combination (A) according to the invention. These oil bodies preferably have a melting point of less than 50 ^° C., more preferably less than 45 ^° C., very preferably less than 40 ^° C., most preferably less than 35 ^° C., and most preferably the cosmetic oils are at a temperature of less than 30 ^° C flowable. In the following, these oils are defined and described in more detail. Examples of natural and synthetic cosmetic oils include: vegetable oils. Examples of such oils are sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of the oil Coconut oil. Also suitable, however, are other triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils. liquid paraffin oils, isoparaffin oils and synthetic hydrocarbons and di-n-alkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as di-n-octyl ether, di-n-decyl ether, di-n-nonyl ether , Di-n-undecyl ether, di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n-undecyl n-dodecyl ether and n-hexyl-n Undecyl ether and di-tert-butyl ether, di-iso-pentyl ether, di-3-ethyldecyl ether, tert-butyl-n-octyl ether, iso-pentyl-n-octyl ether and 2-methyl-pentyl-n-octyl ether. The compounds are available as commercial products 1, 3-di- (2-ethyl-hexyl) - cyclohexane (Cetiol ^® S), and di-n-octyl ether (Cetiol ^® OE) may be preferred. Natural oils include, for example, amaranth seed oil, apricot kernel oil, argan oil, avocado oil, babassu oil, cottonseed oil, borage seed oil, camelina oil, thistle oil, peanut oil, pomegranate seed oil, grapefruit seed oil, hemp oil, hazelnut oil, elderflower seed oil, currant seed oil, jojoba oil, cocoa butter, linseed oil, macadamia nut oil, corn oil, almond oil, marula oil , Evening primrose oil, olive oil, palm oil, rapeseed oil, rice oil, sea buckthorn fruit oil, sea buckthorn seed oil, sesame oil, shea butter, soybean oil, sunflower oil, grapeseed oil, walnut oil or wild rose oil. Preferred oils are argan oil, amaranth seed oil and shea butter. The amount used of the natural and synthetic cosmetic oil bodies in the compositions used according to the invention is usually 0.1 to 30% by weight, based on the total composition, preferably 0.1 to 20% by weight, and in particular 0.1 to 15% by weight. -%. In many cases, the agents contain at least one surface-active substance, with both anionic and zwitterionic, ampholytic, nonionic and cationic surface-active substances being suitable in principle. The choice of surfactants depends on the nature of the agent. In the case of a shampoo, in particular at least one surfactant is selected from the group of anionic, zwitterionic or nonionic surface-active substances. It is preferred here that at least one anionic and at least one zwitterionic surface-active substance is chosen. These surface-active substances are particularly preferably selected from the group of particularly mild surface-active substances. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants. The ratio between anionic and zwitterionic surface-active substances is between 10: 1 and 1: 5. The ratio is particularly preferably 5: 1 to 1: 2. If the composition is a hair-conditioning composition, cationic surfactants are preferably used as surface-active substances or nonionic surfactants selected. Again, a selection of the so-called mild surface-active substances is particularly preferred.

Suitable anionic surfactants (tanion) in preparations according to the invention are all anionic surfactants suitable for use on the human body. Typical examples of anionic surfactants are: linear and branched fatty acids having 8 to 30 carbon atoms (soaps), Ethercarbonsäuren the formula RO- (CH ₂ -CH ₂ O) _x -CH ₂ -COOH, in which R is a linear alkyl group having 8 to 30 carbon atoms and x = 0 or 1 to 16,

Acyl isethionates having 8 to 24 carbon atoms in the acyl group. If one for the esterification fatty acids with 8 to 24 carbon atoms, ie z. As lauric, myristic, palmititic or stearic or technical fatty acid fractions, eg. If, for example, the C ₁₂ -C ₁₈ fatty acid fraction obtainable from coconut fatty acid is used, the C ₁₂ -C ₁₈ acyl isethionates which are preferably suitable according to the invention are obtained.

Sulfobernsteinsäuremono- and dialkyl esters having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups. linear alkanesulfonates having 8 to 24 carbon atoms, linear alpha-olefin sulfonates having 8 to 24 carbon atoms, alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms, alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH ₂ -CH ₂ O) _x -OSO ₃ H in which R is a preferably linear alkyl group having 8 to 30 C atoms and x = 0 or 1 to 12, hydroxysulfonates substantially corresponding to at least one of the following two formulas or mixtures thereof and salts thereof,

CH ₃ - (CH ₂ ) _y -CHOH- (CH ₂ ) _p - (CH-SO ₃ M) - (CH ₂ ) _z -CH ₂ -O- (C _n H _2n O) _x -H, and / or

CH ₃ - (CH ₂ ) _y - (CH-SO ₃ M) - (CH ₂ ) _p -CHOH- (CH ₂ ) _z - CH ₂ -O- (C _n H _2n O) _x -H where in both formulas y and z = 0 or integers from 1 to 18, p = 0, 1 or 2 and the sum (y + z + p) a number from 12 to 18, x = 0 or a number from 1 to 30 and n one an integer from 2 to 4, sulfated hydroxyalkylpolyethylene and / or hydroxyalkylene glycol ethers of the formula R ¹ - (CHOSO ₃ M) -CHR ³ - (OCHR ⁴ -CH ₂ ) n -OR ² with R ¹ , a linear alkyl radical having 1 to 24 C atoms, R ^{2 is} a linear or branched, saturated alkyl radical having 1 to 24 C atoms, R ^{3 is} hydrogen or a linear alkyl radical having 1 to 24 C atoms, R ^{4 is} hydrogen or a methyl radical and n is a number are in the range of 0 to 12 and continue the total number of C atoms contained in R ¹ and R ³ 2 to 44, sulfonates of unsaturated fatty acids having 8 to 24 carbon atoms and 1 to 6 double bonds, esters of tartaric acid and citric acid with alcohols , the adducts of about 2 Represent molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 carbon atoms,

Alkyl and / or alkenyl ether phosphates of the formula

R ¹ (OCH ₂ CH ₂ ) _n -O- (PO-OX) -OR ² , in which R ^{1 is} preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms, R ^{2 is} hydrogen, a radical (CH ₂ CH ₂ O) _{n is} R ² or X, n is from 1 to 10, sulfated fatty acid alkylene glycol esters of the formula RCO (AlkO) _n SO ₃ M in the RCO- for a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 C. Atoms, Alk for CH ₂ CH ₂ , CHCH ₃ CH ₂ and / or CH ₂ CHCH ₃ , n for numbers from 0.5 to 5, Monoglyceride sulfates and monoglyceride ether sulfates of the formula

R ⁸ OC- (OCH ₂ CH ₂ ) _x -OCH ₂ - [CHO (CH ₂ CH ₂ O) _y H] -CH ₂ O (CH ₂ CH ₂ O) _z -SO ₃ X in which R ^{8 is} CO for a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z in total for 0 or for numbers from 1 to 30, preferably 2 to 10, stands. Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and

Tallow fatty acid monoglyceride and its ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts. Preferably monoglyceride sulfates are used, in which R ⁸ CO is a linear acyl radical having 8 to 18 carbon atoms,

- Amidethercarbonsäuren, R ¹ -CO-NR ² -CH ₂ CH ₂ -O- (CH ₂ CH ₂ O) _n CH ₂ COOM, with R ¹ as a straight-chain or branched alkyl or alkenyl radical having a number of carbon atoms in the chain of 2 to 30, n is an integer from 1 to 20 and R ² is hydrogen, methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl or iso-butyl. Such products are obtainable, for example, by the company Chem Y under the product name Akypo ^®.

Acylglutamates of the formula XOOC-CH 2 CH 2 CH (C (NH) OR) -COOX in which RCO is a linear or branched acyl radical having 6 to 22 carbon atoms and 0 and / or 1, 2 or 3 double bonds,

Condensation products of a water-soluble salt of a water-soluble protein hydrolyzate with a C8 - C30 fatty acid. Such products are available under the trademark Lamepon® ^®, Maypon ^®, Gluadin® ^®, Hostapon® ^® KCG or Amisoft ^® commercially, lactylates,

Hydroxymischethersulfate,

Acylsarcosides having 8 to 24 carbon atoms in the acyl group, acyl taurides having 8 to 24 carbon atoms in the acyl group, acyl isethionates having 8 to 24 carbon atoms in the acyl group, sulfosuccinic acid mono- and dialkyl esters,

Alkyl polyglycol ether sulfates of the formula RO (CH ₂ -CH ₂ O) _x -OSO ₃ H,

Esters of tartaric acid and citric acid with alcohols, the addition products of about 2-15

Represent molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 carbon atoms,

Alkyl and / or alkenyl ether phosphates of the formula

R ¹ (OCH ₂ CH ₂ ) _n -O- (PO-OX) -OR ² ,

Monoglyceride sulfates and monoglyceride ether sulfates of the formula

ROC- (OCH ₂ CH ₂ ) _x -OCH ₂ - [CHO (CH ₂ CH ₂ O) _y H] -CH ₂ O (CH ₂ CH ₂ O) _z -SO ₃ X,

Acylglutamates and

Aspartates.

If the mild anionic surfactants contain polyglycol ether chains, it is particularly preferred that they have a narrow homolog distribution. It is still in the case mildly anionic surfactants with polyglycol ether units are preferred in that the number of glycol ether groups is 1 to 20, preferably 2 to 15, more preferably 2 to 12. Particularly mild anionic surfactants having polyglycol ether groups without restricted homolog distribution can be obtained, for example, if, on the one hand, the number of polyglycol ether groups 4 to 12 and Zn or Mg ions are selected as counterion. An example is as commercial product Texapon.RTM ^® ASV.

Of course, all mild and anionic surfactants mentioned heretofore and in the following can also be used in the form of their salts. Particularly suitable mild anionic surfactants are in each case in the form of the lithium, magnesium, zinc, sodium, potassium and ammonium and the mono-, di- and Trialkanolammoniumsalze with 1 to 4 carbon atoms in the alkanol group. The preferred ammonium ions are in addition to the ammonium ion as such monomethylammonium dimethylammonium, trimethylammonium, monoethylammonium, diethylammonium, triethylammonium, monopropylammonium, dipropylammonium, tripropylammonium, monoisopropylammonium, diisopropylammonium, triisopropylammonium,

Monobutylammonium, dibutylammonium, tributylammonium, monoisobutylammonium, diisobutylammonium, triisobutylammonium, mono-t-butylammonium, di-t-butylammonium, tri-t-butylammonium ions and mixed ammonium ions such as, for example, methyl ethylammonium, dimethylethylammonium, methyldiethylammonium, methylpropylammonium, methylethylpropylammonium, ethyldiisopropylammonium, ethyldibutylammonium, ethyldiisobutylammonium ions, etc. Of course, the teaching of the invention also includes the other not explicitly mentioned ammonium ions of these alkanolammonium salts. Further mild anionic surfactants which are very particularly preferably used in the composition according to the invention are alkyl and / or alkenyl oligoglycoside carboxylates, sulfates, phosphates and / or isethionates which are derived from alkyl and / or alkenyl oligoglycosides.

Zwitterionic surfactants (tweets) are those surface-active compounds which carry in the molecule at least one quaternary ammonium group and at least one -COO ⁽⁾ or -SO ₃ ⁽⁾ group. Particularly suitable zwitterionic surfactants are the so-called betaines, such as the N-alkyl-N, N-dimethylammonium glycinates, for example the cocoalkyldimethylammoniumglycinate, N-acylaminopropyl-N, N-dimethylammoniumglycinate, for example the cocoacylaminopropyldimethylammoniumglycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethyl imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine. Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group. Typical examples of amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, amino-propionates, aminoglycinates, imidazolinium betaines and sulfobetaines. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C ₁₂ -C ₁₈ -acylsarcosine.

Nonionic surfactants (Tnio) contain as hydrophilic group e.g. a polyol group, one

Polyalkylene glycol ether group or a combination of polyol and Polyglykolethergruppe.

Such compounds are, for example

Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide onto linear and branched fatty alcohols having 6 to 30 carbon atoms, the fatty alcohol polyglycol ethers or the fatty alcohol polypropyleneglycol ethers or mixed fatty alcohol polyethers,

Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty acids having 6 to 30 carbon atoms, the fatty acid polyglycol ethers or the Fettsäurepolypropylenglykolether or mixed fatty acid polyethers,

Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched alkylphenols having 8 to 15 carbon atoms in the alkyl group, the

Alkylphenolpolyglykolether or the Alkylpolypropylenglykolether, or mixed

Alyklphenolpolyether, with a methyl or C ₂ - C ₆ - alkyl radical end-capped addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched

Fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 carbon atoms and alkylphenols having 8 to 15 carbon atoms in the alkyl group, such as those among the

Sales names Dehydrol® ^® LS, Dehydrol® ^® LT (Cognis) types,

C ₁₂ -C ₃₀ -fatty acid mono- and diesters of addition products of 1 to 30 moles of ethylene oxide with glycerol,

Addition products of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,

Polyol fatty acid esters, such as the commercial product Hydagen ^® HSP (Cognis) or

Sovermol ^® - types (Cognis), alkoxylated triglycerides, alkoxylated fatty acid alkyl esters of formula (Tnio-1)

R ¹ CO- (OCH ₂ CHR ² ) _W OR ³ (Tnio-1) in the R ¹ CO for a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R ^{2 is} hydrogen or methyl, R ³ for linear or branched

Alkyl radicals having 1 to 4 carbon atoms and w is from 1 to 20,

Amine oxides,

- Hydroxymischether, the formula R ¹ O [CH ₂ CH (CH ₃ ) O] _x (CH ₂ CHR ² O) _y [CH ₂ CH (OH) R ³ ] _z with R ^{1 is} a linear or branched, saturated or unsaturated alkyl and / or alkenyl radical having 2 to 30 C atoms, R ^{2 is} hydrogen, a methyl, ethyl, propyl or iso-propyl radical, R ^{3 is} a linear or branched alkyl radical having 2 to 30 C - Atoms, x standing for 0 or a number from 1 to 20, Y for a number from 1 to 30 and z standing for the number 1, 2, 3, 4 or 5.

Sorbitan fatty acid esters and adducts of ethylene oxide with sorbitan fatty acid esters such as the polysorbates, Sugar fatty acid esters and addition products of ethylene oxide with sugar fatty acid esters, addition products of ethylene oxide onto fatty acid alkanolamides and fatty amines, sugar surfactants of the alkyl and alkenyl oligoglycoside type according to formula (E4-II), in which R ^{4 is} an alkyl or alkenyl radical having 4 to 22 carbon atoms, G is a sugar radical having 5 or 6 carbon atoms and p is a number from 1 to 10. Sugar surfactants of the fatty acid N-alkyl polyhydroxyalkylamide type, a nonionic surfactant of the formula (Tnio-3),

R ⁵ CO-NR ⁶ - [Z] (Tnio-3) in the R ⁵ CO for an aliphatic acyl radical having 6 to 22 carbon atoms, R ^{6 is} hydrogen, an alkyl or hydroxyalkyl radical having 1 to 4 carbon atoms and [Z] a linear or branched polyhydroxyalkyl having 3 to 12 carbon atoms and 3 to 10 hydroxyl groups.

The sugar surfactants may preferably be present in the agents used according to the invention in amounts of from 0.1 to 20% by weight, based on the total agent. Amounts of 0.5-15% by weight are preferred, and most preferred are amounts of 0.5-7.5% by weight. Other typical examples of nonionic surfactants are fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, mixed ethers or mixed formalin, protein hydrolysates (especially wheat-based vegetable products) and polysorbates.

As preferred nonionic surfactants, the alkylene oxide adducts to saturated linear fatty alcohols and fatty acids having in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid and the sugar surfactants have proven. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants.

These connections are identified by the following parameters. The alkyl radical R contains 6 to 22 carbon atoms and may be both linear and branched. Preference is given to primary linear and methyl-branched in the 2-position aliphatic radicals. Such alkyl radicals are, for example, 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. Particularly preferred are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl. When using so-called "oxo-alcohols" as starting materials, compounds with an odd number of carbon atoms in the alkyl chain predominate.

The compounds used as surfactant with alkyl groups may each be uniform substances. However, it is usually preferred to start from the production of these substances from native plant or animal raw materials, so as to obtain substance mixtures with different, depending on the particular raw material alkyl chain lengths.

A very particularly preferred embodiment additionally contains at least one further cationic compound in addition to the obligatory ingredients according to the statements made above. This cationic compound may be further a cationic surfactant and / or another cationic polymer or at least one cationic surfactant each and a cationic polymer. Under cationic is in the sense of the invention under this

Embodiment to understand an amphoteric polymer. For the description and definition of both the other cationic surfactants and the cationic and / or amphoteric

Polymers will be discussed in the following description.

Cationic surfactants (Tkat) are generally derived from ammonium ions and have a

structure

(NR ¹ R ² R ³ RV A ^~ (Tkati) with a corresponding negatively charged counterion A. Such cationic

Ammonium compounds are well known to those skilled in the art. The radicals R 1 to R 4 may each independently of one another comprise straight-chain, branched, cyclic, aromatic saturated or unsaturated alkyl and / or alkenyl chains having at least 1 to 30 carbon atoms,

Hydrogen, -OH or hydroxyethyl mean.

Further cationic surfactants are, for example, the esterquats or the imidazolium compounds.

Cationic surfactants (Tkat) of the quaternary ammonium compound type, the esterquats and the imidazolines are particularly preferably used according to the invention. These have already been described in detail previously.

Preferred quaternary ammonium compounds are ammonium halides, in particular

Chlorides and bromides, such as dialkyldimethylammonium chlorides, e.g. Distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and

Tricetylmethylammonium chloride.

According to the invention, cationic compounds having at least two behenyl radicals are particularly preferably usable. Commercially available these substances are, for example, under the

Designations Genamin ^® KDMP (Clariant).

Another example of a suitable cationic surfactant, quaternary sugar derivative is the commercially available product Glucquat ^® 100 is, according to INCI nomenclature a "lauryl methyl Gluceth-10

Hydroxypropyl Dimonium Chloride ".

Of course, the teaching of the invention also includes the recognition that mixtures of at least two cationic surfactants can be used. In this case, the cationic surfactants are preferably selected from at least two different structural classes of cationic surfactants.

These other optional cationic surfactants (Tkat) are used in the invention

Agents preferably in amounts of 0.05 to 10 wt .-%, based on the total agent included.

Amounts of 0.1 to 5 wt .-% are particularly preferred.

Of course, it is also preferable in the case of the cationic surfactants to select mild cationic surfactants. The corresponding mild cationic surfactants include in particular alkylamidoamines, quaternized amidoamines, esterquats, cationic surfactants of

Formula (Tkat-2) and cationic surfactants having at least one behenyl radical in the molecule.

Cationic, zwitterionic and / or amphoteric surfactants and mixtures thereof may be preferred according to the invention. Anionic surfactants are used in particular when the compositions according to the invention are to be used as shower baths. The surfactants (T) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total agent used according to the invention , Emulsifiers which can be used according to the invention are, for example

Addition products of 4 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear fatty alcohols having 8 to 22 carbon atoms, to fatty acids having 12 to 22 carbon atoms and on

Alkylphenols having 8 to 15 C atoms in the alkyl group,

C ₂ -C ₂₂ -fatty acid mono- and diesters of addition products of from 1 to 30 mol of ethylene oxide onto polyols having from 3 to 6 carbon atoms, in particular to glycerol,

Ethylene oxide and polyglycerol addition products to methyl glucoside fatty acid esters,

Fatty acid alkanolamides and fatty acid glucamides,

C ₈ -C ₂₂ -alkylmono- and -oligoglycosides and their ethoxylated analogues, where C ¹ degrees of gyration of from 1.1 to 5, in particular 1.2 to 2.0, and glucose as sugar component are preferred,

Glucosides mixtures of alkyl (oligo) and fatty alcohols, for example, the commercially available product ^® Montanov 68,

Partial esters of polyols having 3-6 carbon atoms with saturated fatty acids having 8 to 22 C

atoms,

Sterols, for example as zosterine cholesterol and lanosterol, as phytosterols

Ergosterol, stigmasterol and sitosterol.

Phospholipids, e.g. Lecithins or phosphatidylcholines from egg yolk or plant seeds (e.g.

Soybeans)

Fatty acid esters of sugars and sugar alcohols, such as sorbitol,

Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate

(Dehymuls ^® PGPH commercial product)

Linear and branched fatty acids with 8 to 30 C atoms and their Na, K, ammonium,

Ca, Mg and Zn salts.

The agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.

The compositions according to the invention may preferably contain at least one nonionic emulsifier having an HLB value of 8 to 18. Nonionic emulsifiers having an HLB value of 10 to 15 may be particularly preferred according to the invention. Emulsifiers preferred according to the invention are the so-called mild emulsifiers. The anionic polymers are anionic polymers which have carboxylate and / or sulfonate groups. Examples of anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid. The acidic groups can be completely or partly example, be present as sodium, potassium, ammonium, mono- or triethanolammonium salt. Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid. Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for the sulfonic acid group to be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt ,

More preferably, the homopolymer of 2-acrylamido-2-methylpropansulfon acid, which is available for example under the name Rheothik ^® 11-80 is commercially. Within this embodiment, it may be preferable to use copolymers of at least one anionic monomer and at least one nonionic monomer. With regard to the anionic monomers, reference is made to the substances listed above. Preferred nonionic monomers are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters.

Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers. A particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt is present. This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used. Such a polymer is contained in the commercial product Sepigel ^® 305 from SEPPIC. The use of this compound, which in addition to the polymer component contains a hydrocarbon mixture (C ₁₃ -C ₄ -lsoparaffin) and a non-ionic emulsifier (laureth-7), has proved to be particularly advantageous within the scope of the teaching according to the invention. Also sold under the name Simulgel ^® 600 as a compound with isohexadecane and polysorbate-80 Natriumacryloyldimethyltaurat copolymers have proved to be particularly effective according to the invention.

Likewise preferred anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ^® commercially.

Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers. A 1, 9-decadiene crosslinked maleic acid methyl vinyl ether copolymer is available under the name ^® Stabileze QM. The anionic polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.

In a further embodiment, the agents according to the invention may contain nonionogenic polymers. Suitable nonionic polymers are, for example:

Vinylpyrrolidone / vinyl ester copolymers, as sold, for example, under the trademark Luviskol ^® (BASF). Luviskol ^® VA 64 and Luviskol ^® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers. Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy-, as sold for example under the trademark Culminal® ^® and Benecel ^® (AQUALON) and Natrosol ^® grades (Hercules).

Starch and its derivatives, in particular starch, such as Structure XL ^® (National Starch), a multifunctional, salt-tolerant starch; shellac

Polyvinylpyrrolidones, as sold for example under the name Luviskol ^® (BASF).

The nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.

The polymers (P) are preferably present in the compositions used according to the invention in amounts of from 0.01 to 30% by weight, based on the total composition. Amounts of from 0.01 to 25, in particular from 0.01 to 15 wt .-%, are particularly preferred.

The following ingredients additionally contribute to the achievement and further enhancement of the effects of the invention.

With particular preference the compositions according to the invention contain fatty substances (fat) as further active ingredient.

Fat substances (fat) are understood to mean fatty acids, fatty alcohols, natural and synthetic waxes, which can be in solid form as well as liquid in aqueous dispersion, and natural and synthetic cosmetic oil components.

As fatty acids (Fatac) can be used linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ^® 871 and Emersol ^® 875, and isopalmitic acids such as the commercial product Edenor ^® IP 95, and all other products sold under the trade names Edenor ^® (Cognis) fatty acids. Further typical examples of such fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic as well as their technical mixtures. Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred. The amount used is 0.1 - 15 wt.%, Based on the total mean. The amount is preferably 0.5-10% by weight, with amounts of 1-5% by weight being particularly advantageous.

As fatty alcohols (fatal) it is possible to use saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C ₆ -C ₃₀ -, preferably C ₁₀ -C ₂₂ -and very particularly preferably C ₁₂ -C ₂₂ -carbon atoms. Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character. However, the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction. Also usable according to the invention are those fatty alcohol cuts which are produced by reducing naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols. Such substances are, for example, under the names Stenol ^® such as Stenol ^® 1618 or Lanette ^® such as Lanette ^® O or Lorol ^®, for example, Lorol ^® C8, Lorol C14 ^®, Lorol C18 ^®, ^® Lorol C8-18, HD Ocenol ^®, Crodacol ^® such as Crodacol ^® CS, Novol ^®, Eutanol ^® G, Guerbitol ^® 16, Guerbitol ^® 18, Guerbitol ^® 20, Isofol ^® 12, Isofol ^® 16, Isofol ^® 24, Isofol ^® 36, Isocarb ^® 12, Isocarb ^® 16 or acquire Isocarb® ^® 24 for sale. Of course, wool wax alcohols, as are commercially available, for example under the names of Corona ^®, White Swan ^®, Coronet ^® or Fluilan ^® can be used according to the invention. The fatty alcohols are used in amounts of from 0.1 to 30% by weight, based on the total preparation, preferably in amounts of from 0.1 to 20% by weight.

As natural or synthetic waxes (Fatwax), solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP can be used according to the invention. Such waxes are available, for example, from Kahl & Co., Trittau.

The amount used is 0.1-50 wt.% Based on the total agent, preferably 0.1 to 20 wt.% And particularly preferably 0.1 to 15 wt.% Based on the total agent. The total amount of oil and fat components in the compositions according to the invention is usually 0.5-75% by weight, based on the total agent. Amounts of 0.5-35 wt .-% are preferred according to the invention.

Another inventive synergistic active ingredient in the compositions according to the invention with the active ingredient complex according to the invention are protein hydrolysates and / or derivatives thereof (Pro). According to the invention, the term protein hydrolyzates also means total hydrolyzates as well as individual amino acids and their derivatives as well as mixtures of different amino acids. Furthermore, according to the invention, polymers made up of amino acids and amino acid derivatives are understood by the term protein hydrolyzates. The latter include, for example, polyalanine, polyasparagine, polyserine, etc. Further examples of compounds which can be used according to the invention are L-alanyl-L-proline, polyglycine, glycyl-L-glutamine or D / L-methionine-S-methylsulfonium chloride. Of course, according to the invention, β-amino acids and their derivatives such as β-alanine, anthranilic acid or hippuric acid can also be used. The molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.

Examples of amino acids and their derivatives as protein hydrolysates according to the invention are: alanine, arginine, carnitine, creatine, cystathionine, cysteine, cystine, cystic acid, glycine, histidine, homocysteine, homoserine, isoleucine, lanthionine, leucine, lysine, methionine, norleucine, norvaline , Ornithine, phenylalanine, proline, hydroxyproline, sarcosine, serine, threonine, tryptophan, thyronine, tyrosine, valine, aspartic acid, asparagine, glutamic acid and glutamine. Preferred amino acids are alanine, arginine, glycine, histidine, lanthionine, leucine, lysine, proline, hydroxyproline serine and asparagine. Alanine, glycine, histidine, lysine, serine and arginine are very particularly preferably used. Most preferably, glycine, histidine, lysine and serine are used.

According to the invention, protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.

Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein hydrolysates, which may also be present in the form of salts. Such products are, for example, under the trademarks Dehylan ^® (Cognis), Promois® ^® (Interorgana) Collapuron ^® (Cognis), Nutrilan® ^® (Cognis), Gelita-Sol ^® (German Gelatinefabriken Stoess & Co), Lexein ^® (Inolex) and kerasol tm ^® (Croda) sold.

Further preferred vegetable protein hydrolysates according to the invention are, for example, soybean, almond, pea, moringa, potato and wheat protein hydrolysates. Such products are, for example, under the trademarks Gluadin ^® (Cognis), diamine ^® (Diamalt) ^® (Inolex), Hydrosoy ^® (Croda), hydro Lupine ^® (Croda), hydro Sesame ^® (Croda), Hydro tritium ^® (Croda), Crotein ^® (Croda) or Puricare ^® LS 9658 (Laboratoires Serobiologiques).

Further preferred protein hydrolysates according to the invention are, for example, collagen hydrolyzates of fish or algae and protein hydrolysates of mussels or pearl hydrolysates. Examples of pearl extracts according to the invention are the commercial products Pearl Protein Extract BG ^® or Crodarom ^® Pearl.

The protein hydrolysates (Pro) are present in the compositions in concentrations of 0.001% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and most preferably in amounts of 0.05% by weight. up to 5% by weight. The effect of the compositions according to the invention can be further increased by a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J). Preference is given to the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion carries, in addition to hydrogen, one to three C ₁ - to C ₄ -alkyl groups. The sodium salt is most preferred. The amounts used in the inventive compositions are 0.05 to 10 wt.%, Based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt.%.

Another preferred group of ingredients of the compositions according to the invention with the active ingredient according to the invention complex are vitamins, provitamins or vitamin precursors. Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.

The group of substances called vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A ₂ ). The ß-carotene is the provitamin of retinol. As vitamin A component according to the invention, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration. The agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation. The vitamin B group or the vitamin B complex include vitamin B ₁ (thiamine) vitamin B ₂ (riboflavin)

Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.

Vitamin B ₅ (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group. Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are, for example, panthenol triacetate, panthenol monoethyl ether and its monoacetate, as well as cationic panthenol derivatives. The said compounds of the vitamin B ₅ type are preferably contained in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred.

Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal).

Vitamin C (ascorbic acid). Vitamin C is used in the agents according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.

Vitamin E (tocopherols, especially α-tocopherol). Tocopherol and its derivatives, which include in particular the esters such as acetate, nicotinate, phosphate and succinate, are in the inventive compositions preferably in amounts of 0.05-1 wt .-%, based on the total agent.

Vitamin F. The term "vitamin F" is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.

Vitamin H. Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed. Biotin is preferred in the agents according to the invention in amounts of from 0.0001 to

1, 0 wt .-%, in particular in amounts of 0.001 to 0.01 wt .-%.

The compositions according to the invention preferably contain vitamins, provitamins and

Vitamin precursors from groups A, B, E and H. Panthenol, pantolactone, pyridoxine and its

Derivatives as well as nicotinic acid amide and biotin are particularly preferred.

Finally, the use of plant extracts (L) in the compositions according to the invention gives rise to further synergistic advantages.

According to the invention, especially the extracts of green tea, oak bark, stinging nettle,

Witch hazel, hops, henna, chamomile, burdock root, horsetail, hawthorn, lime blossom,

Almond, aloe vera, spruce needle, horse chestnut, sandalwood, juniper, coconut, mango,

Apricot, lime, wheat, kiwi, melon, orange, grapefruit, sage, rosemary, birch, mallow,

Valerian, Meadowfoam, Quendel, Yarrow, Thyme, Melissa, Toadstool, Coltsfoot,

Marshmallow, meristem, ginseng, coffee, cocoa, moringa and ginger root are preferred.

Another particularly preferred plant extract is an extract obtainable from plants of the

Genus Echinacea used.

Preferred compositions of the invention contain purine and / or purine derivatives in narrower ranges. Here are inventively preferred cosmetic agents characterized in that they - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular from 0.01 to 0.1% by weight

Purine (s) and / or purine derivative (s).

Among purine, the purines and the purine derivatives, some representatives are particularly preferred according to the invention. Cosmetic agents preferred according to the invention are characterized in that they

Purine, adenine, guanine, uric acid, hypoxanthine, 6-purinethiol, 6-thioguanine, xanthine, caffeine,

Theobromine or theophylline included. Caffeine has proved particularly useful in hair cosmetic formulations, for example in shampoos, conditioners, hair lotions and / or lotions, preferably in amounts of from 0.005 to 0.25% by weight, more preferably from 0.01 to 0.1% by weight and in particular from 0.01 to 0.05 wt .-% (in each case based on the

Composition) can be used.

Another preferred active ingredient in the agents according to the invention is taurine (2-

Aminoethanesulfonic). Preferred taurine derivatives are N-monomethyltaurine and N, N-

Dimethyltaurine. Other taurine derivatives in the context of the present invention are the

Taurocholic acid and hypotaurine. Particularly preferred are agents according to the invention, which - based on their weight - 0.0001 to 10.0 wt .-%, preferably 0.0005 to 5.0 wt .-%, particularly preferably 0.001 to 2.0 wt .-% and In particular, 0.001 to 1, 0 wt .-% taurine and / or a derivative of taurine included. In addition, it may prove advantageous if the compositions according to the invention contain penetration aids and / or swelling agents (M). These include, for example, urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives, water glass, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ethers, propylene glycol and propylene glycol ethers, for example propylene glycol monoethyl ether, carbonates, bicarbonates, Diols and triols, and in particular 1, 2-diols and 1, 3-diols such as 1, 2-propanediol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-dodecanediol, 1, 3-propanediol, 1 , 6-hexanediol, 1, 5-pentanediol, 1, 4-butanediol. Another group of very particular ingredients of the compositions of the invention are biochinones. Particularly preferred according to the invention is the ubiquinone which is known as coenzyme Q10.

The or the biochinone (s) is (are) in the inventive compositions - by weight - in an amount of 0.0000005 to 2%, preferably in an amount of 0.000001 to 1% and in particular in an amount of 0 , 00001 to 0.5%.

Another particularly preferred group of ingredients in the cosmetic compositions of the invention are betaines. Examples of particularly suitable betaines according to the invention are: carnitine, carnitine tartrate, carnitine magnesium citrate, acetyl carnitine, 3-O-lauroyl L-carnitine hydrochloride, SO-octanoyl L-carnitine hydrochloride, 3-O-palmitoyl- L-carnitine hydrochloride, taurine, taurine lysylate, taurine tartrate, taurine ornithine, lysyl taurine and ornithyl taurine, betalain, 1, 1-dimethyl-proline, hercynin (Nα, Nα, Nα -trimethyl-L-histidinium betaine), ergothioneine (thionein, 2 Mercapto-Nα, Na, Na-trimethyl-L-histidinium betaine), choline, choline chloride, choline bitartrate, choline dihydrogen citrate, and the compound N, N, N-trimethylglycine referred to in the literature as betaine. These mixed salts may be preferred according to the invention. The agents according to the invention contain the betaines in amounts of from 0.001 to 20% by weight, based on the total agent. A content of 0.05 to 10 wt .-% is preferred.

Furthermore, the cosmetic compositions according to the invention may contain pharmacologically active substances to achieve certain effects, such as, for example, an anti-dandruff effect or effects against acne.

These substances are contained in amounts of from 0.01 to 10% by weight, based in each case on the entire composition.

Other ingredients that can be used in cosmetic compositions are preservatives. Preservatives used are the substance classes listed in Appendix 6, Parts A and B of the European Cosmetics Regulation. Particularly preferred is mild preservation, ideally without the addition of typical preservatives. In a further embodiment, the agents according to the invention should additionally contain at least one UV light protection filter. UVB filters can be oil-soluble or water-soluble. Furthermore, the cosmetic agents may contain other active ingredients, auxiliaries and additives, such as

Dimethylisosorbide and cyclodextrins,

Solvents and mediators,

Dyes for staining the agent,

Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,

Active ingredients such as bisabolol,

Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids,

Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers

Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,

pigments

Propellants such as propane-butane mixtures, N ₂ O, dimethyl ether, CO ₂ and air. With regard to further optional components and the amounts of these components used, reference is expressly made to the relevant manuals known to the person skilled in the art. As already mentioned, the high care effect of the agents according to the invention is of particular importance, in particular, since it gives excellent results even in the presence of oxidizing agents, for example in the context of oxidative hair dyeing.

A second subject of the invention is therefore a method for hair treatment, in which a cosmetic composition according to claim 1 is applied to the hair and rinsed after a contact time of the hair.

The exposure time is preferably a few seconds to 100 minutes, more preferably 1 to 50 minutes and most preferably 1 to 30 minutes.

The following examples are intended to illustrate the subject matter of the present invention without, however, limiting it.

Beis piele

All quantities are, unless otherwise stated, parts by weight.

The following formulations were provided using known preparation methods.

flush

Claims

claims:

A hair conditioning composition comprising a) at least 0.01% by weight of a quaternary imidazoline derivative having at least two long fat residues according to the formula Ia and b) at least two ester oils, c) a cosmetic carrier and d) no silicone

2. Composition according to claim 1, characterized in that at least one of the ester oils is selected from the esters of carbonic acid with fatty alcohols.

3. Composition according to one of claims 1 or 2, characterized in that the ester of carbonic acid with the fatty alcohols is selected from the symmetrical esters of carbonic acid with fatty alcohols.

4. Composition according to one of claims 1 to 3, characterized in that at least one of the ester oils is selected from the ester oils of the formula (D4-II).

5. Composition according to one of claims 1 to 4, characterized in that it further contains at least one further cationic compound.

6. Composition according to one of claims 1 to 5, characterized in that the further cationic compound is a cationic polymer.

7. Composition according to one of claims 1 to 6, characterized in that it additionally contains at least one substance from the group of vitamins, provitamins and vitamin precursors and their derivatives, with vitamins, pro-vitamins and vitamin precursors are preferred, the groups A, B, C, E, F and H are assigned.

8. Use of a preparation according to any one of claims 1 to 7 for the purification of skin and hair.

9. Use of a preparation according to one of claims 1 to 8 for the restructuring of keratinic fibers, in particular human hair.

10. A method for the treatment of skin or hair, wherein a preparation according to any one of claims 1 to 7 is applied to the skin and / or the hair, wherein the preparation is rinsed again after a contact time of 0 to 45 minutes.

11. A method for the treatment of skin or hair, wherein a preparation according to any one of claims 1 to 8 applied to the skin and / or hair and left there until the next wash.